TScan Therapeutics, Inc.·4

Dec 29, 2:34 PM ET

Silver Brian M. 4

4 · TScan Therapeutics, Inc. · Filed Dec 29, 2022

Insider Transaction Report

Form 4
Period: 2022-12-27
Silver Brian M.
Chief Financial Officer
Transactions
  • Purchase

    Voting Common Stock

    2022-12-27$1.50/sh+2,842$4,27629,727 total
  • Purchase

    Voting Common Stock

    2022-12-28$1.56/sh+3,158$4,94132,885 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $1.46 to $1.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $1.55 to $1.57, inclusive.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION